A biotechnology company known for developing small-molecule pharmaceuticals for infectious diseases, inflammatory diseases and cancer. It was founded in 1986 and has headquarters in Durham, North Carolina.
October 18, 2012
BioCryst Pharmaceuticals acquires the company, which focuses on therapies for viruses.
October 20, 2010
The company acquires the contract research organization.
1986
The company is founded in Durham, North Carolina.